We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current JAGX market cap is 3.07M. The company's latest EPS is USD -37.7985 and P/E is -0.07.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.35M | 2.72M | 3.11M | 3.51M | 2.21M |
| Operating Income | -8.22M | -7.2M | -7.26M | -8.16M | -9.42M |
| Net Income | -9.23M | -9.49M | -9.85M | -9.92M | -10.46M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 9.39M | 4.34M | 11.96M | 9.76M | 11.69M |
| Operating Income | -26.61M | -40.71M | -34.42M | -34.29M | -30.83M |
| Net Income | -38.61M | -52.6M | -47.45M | -41.3M | -38.49M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 55.39M | 61.46M | 58.47M | 53.43M | 51.46M |
| Total Liabilities | 41.09M | 42.4M | 42.88M | 44.45M | 48.15M |
| Total Equity | 11.82M | 16.58M | 13.1M | 6.49M | 830k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 42.84M | 53.27M | 47.45M | 50.76M | 53.43M |
| Total Liabilities | 25.64M | 41.41M | 48.81M | 45.87M | 44.45M |
| Total Equity | 17.2M | 11.85M | -1.36M | 4.9M | 6.49M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.05M | -15.22M | -21.56M | -29.38M | -7.32M |
| Investing | N/A | -16k | -16k | -231k | N/A |
| Financing | 12.27M | 24.84M | 28.37M | 31.2M | 4.97M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.28M | -34.97M | -33.1M | -33.24M | -29.38M |
| Investing | -7k | -6k | -1.68M | N/A | -231k |
| Financing | 19.49M | 43.94M | 23.18M | 34.23M | 31.2M |
| Market Cap | 3.07M |
| Price to Earnings Ratio | -0.07 |
| Price to Sales Ratio | 0.24 |
| Price to Cash Ratio | 0.35 |
| Price to Book Ratio | 0.31 |
| Dividend Yield | - |
| Shares Outstanding | 1.02M |
| Average Volume (1 week) | 81.8k |
| Average Volume (1 Month) | 98.58k |
| 52 Week Change | -96.78% |
| 52 Week High | 110.75 |
| 52 Week Low | 2.77 |
| Spread (Intraday) | 0.25 (8.2%) |
| Company Name | Jaguar Health Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://jaguar.health |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
